Improving genetic counseling for at-risk relatives of cancer patients
Official title: Family HOPE Study (Hereditary Lynch Syndrome Opportunities for Participation &Amp; Engagement)
Run by City of Hope Medical Center · NCT05772130 · Data updated 2026-11-12
This study is testing if talking directly with a healthcare provider about genetic testing results can help at-risk family members of cancer patients get tested more often and feel better about it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | City of Hope Medical Center Academic / other |
| Locations | 1 site (Duarte, California) |
| Status | Recruiting |
| Started | March 10, 2023 |
| Main results expected | December 21, 2026 |
| Study ends | December 21, 2026 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT05772130 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include cancer patients with a pathogenic germline variant who have at least two first-degree relatives eligible for genetic testing.
✕Probably not a fit
Patients without a pathogenic germline variant or those who do not have at least two at-risk first-degree relatives may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates whether provider-mediated communication of genetic testing results can enhance genetic counseling and testing rates among at-risk relatives of cancer patients. Participants are randomized into two groups: one receives a family letter and genomic test report, while the other receives the same materials along with direct provider contact to discuss the genetic results. The study aims to improve cascade testing rates and assess the psychosocial impact of this communication method. It targets individuals with inherited cancer risk due to pathogenic gene variants.
Why it matters
Potential benefit: If successful, this approach could significantly increase awareness and access to genetic testing for at-risk family members, leading to earlier detection and prevention of cancer.
How similar studies have gone: Other studies have shown success with similar provider-mediated communication approaches in improving genetic counseling and testing rates.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * PATIENTS: Enrolled in City of Hope (COH) institutional review board (IRB) 07047 or have been seen by COH Genetics for genetic testing * PATIENTS: Have an pathogenic/ likely pathogenic germline variant * PATIENTS: Fluent in English * PATIENTS: Age \>= 18 years * PATIENTS: Willing to provide contact information for eligible first-degree relatives * PATIENTS: \>= 2 first-degree relatives that are eligible for genetic testing and reside in the United States of America * FIRST-DEGREE RELATIVES: Proband is a COH patient and has consented to this study * FIRST-DEGREE RELATIVES: First-degree relative of proband * FIRST-DEGREE RELATIVES: Resides within the United States * FIRST-DEGREE RELATIVES: Has not undergone genetic testing for the known familial variant * FIRST-DEGREE RELATIVES: Are fluent in English * FIRST-DEGREE RELATIVES: Age \>= 18 years Exclusion Criteria: * PATIENTS: Unable to provide informed consent * PATIENTS: =\< 2 at-risk first-degree relatives who are eligible for genetic testing and/or reside within the United States * PATIENTS: Unwilling to provide contact information for family members * FIRST-DEGREE RELATIVES: Unable or unwilling to provide informed consent * FIRST-DEGREE RELATIVES: Have undergone genetic testing for the known familial variant * FIRST-DEGREE RELATIVES: Resides outside of the United States
Where it's running
-
City of Hope Medical Center
Duarte, California, United States Recruiting
Study contacts
- Principal investigator: Stacy W Gray — City of Hope Medical Center
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality to reduce psychological symptom burden during cancer treatment
This trial will try virtual reality sessions to reduce anxiety, depression, and adjustment symptoms for adults receiving cancer treatment.
-
Connecting underrepresented populations to clinical trials at Ohio State University
This study is trying to find better ways to connect racial and ethnic minorities to cancer clinical trials at Ohio State University to help them participate more.
-
Virtual group therapy to improve psychological wellbeing in cancer patients
This study is testing if virtual group therapy that combines acceptance and commitment therapy with compassion can help improve the mental wellbeing of cancer patients.
-
Community-based exercise program for cancer survivors
This study tests a 12-week exercise program for cancer survivors to see if it helps them feel better and improves their quality of life.
-
New blood and urine tests for cancer screening
This study is testing new blood and urine tests for cancer screening to see how well they work in people without known cancer and how different health factors might affect the results.
-
Telemedicine support for older cancer patients in underserved communities
This study tests whether using telemedicine to provide extra support can help older cancer patients in underserved communities feel better and have fewer hospital visits compared to standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.